Abbott has completed acquisition of Cardiovascular Systems for $890 million. Company develops solutions for revascularization of patients with complex coronary and peripheral artery disease.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept